Sort by
Refine Your Search
-
Listed
-
Country
-
Program
-
Employer
- ;
- AcademicTransfer
- RMIT University
- Amsterdam UMC
- Karolinska Institutet
- Technical University of Munich
- UiT The Arctic University of Norway
- ; The University of Manchester
- ; University of Cambridge
- ; University of East Anglia
- ; University of Southampton
- ; University of Surrey
- Australian Academy of Science Research Funding
- Australian Rotary Health PhD Scholarships
- CNRS
- Delft University of Technology
- Delft University of Technology (TU Delft)
- ETH Zurich
- Griffith University
- Helmholtz
- IRTA
- Institut Lumière Matière ILM- UMR 5306 CNRS / Université Claude Bernard Lyon 1
- International PhD Programme (IPP) Mainz
- Leiden University
- Slovak University of Agriculture in Nitra
- Technical University of Denmark
- Trinity College Dublin
- University Medical Centre Groningen (UMCG)
- University of Cambridge
- University of Copenhagen
- University of Nicosia Medical School
- University of Nottingham
- University of Porto
- Uppsala University
- 24 more »
- « less
-
Field
-
View All Vacancies Veterinary Medicine & Science Location: UK Other Closing Date: Wednesday 14 August 2024 Reference: MED2008 Project title: Development and application of recombinant antibodies
-
diagnosed with RA. The van Egmond lab investigates the activation of neutrophils by (auto-)antibodies, and demonstrated that particularly antibodies of the IgA isotype potently activate neutrophils, and
-
PhD Studentship - Extending the Chemical Space of mAb Based Cancer Treatment with DNA Nanostructures
studentship in interdisciplinary cancer research, starting in October 2024. The highly motivated student will receive high-level interdisciplinary training in DNA and monoclonal antibody chemistry and
-
antibodies is a leading strategy for treating Alzheimer's disease. However, the development of biological drugs for brain diseases is complicated by the blood-brain barrier, which prevents large molecules from
-
of neutralising antibodies in blood, a role for the adaptive immune system is envisaged. The approaches to study the host-pathogen interaction of PRRSV-1 shall include the: Analysis of the T and B cell repertoire
-
Primary supervisor - Dr Amit Sachdeva Secondary supervisor - Prof Andy Cammidge Over the last decade, several antibody-based biotherapeutics have been developed for treatment of cancer
-
proteins relevant to disease. This includes protein and antibody production, generation of knockout cell lines, development of functional assay, insights in structural information via X-Ray crystallography
-
to enrich our current knowledge on the absorption bands. 3) Monoclonal antibodies directed against ECM polysaccharides from S. latissima has been obtained in the lab and await characterization
-
the use of neutralising antibodies. The approaches to study the host-pathogen interaction of PRRSV-1 in vitro and in vivo shall include the: Use of in vitro systems to demonstrate effect of infection on APC
-
Institut Lumière Matière ILM- UMR 5306 CNRS / Université Claude Bernard Lyon 1 | Villeurbanne, Rhone Alpes | France | about 2 months ago
antibody-antigen binding events, serving as a proof of concept. Since the sensing mechanism of SAW devices relies primarily on mass-loading to detect binding events, resolution can be limited by the low mass